Abstract
In a multicentric and interdisciplinary approach the German Collaborative Study of Children Treated for Phenylketonuria (PKU) investigates prospectively the effects of early started strict dietary treatment on the growth and development of 140 patients. The present paper focuses on longitudinal intelligence data from 4, 5 and 9 years of age of 89 patients in relation to the quality of dietary control in comparison to 200 healthy children tested by the same protocol. Cluster analysis of phenylalanine (Phe) levels distinguished a cluster of good dietary control with Phe levels according to the recommendation of maintaining Phe levels below 360 µmol/1, a cluster of poor dietary control with Phe levels greater than 600 µmol/1 after the age of 3 years, and a cluster of intermediate control. Intelligence quotients (IQ) and Phe clusters were inversely related with non-significant differences between the clusters good and intermediate. On average, all three clusters scored significantly lower than healthy age peers. Mean IQ scores decreased for patients as well as for healthy children due to different tests used at different measurement occasions. Patients with poor dietary control showed a steeper decrease between 4 and 5 years than patients with better dietary control. Between 5 and 9 years IQ differences between patients and healthy children remained stable. Verbal IQs were higher than performance IQs for patients as well as for healthy children. It is concluded that after early and strict treatment during the pre-school years Phe levels, in the range observed, do not influence IQ development until the age of 9 years. IQ subscale pattern indicate that PKU results in a generalized reduction of IQ instead of disturbing specific abilities. It remains to be investigated whether higher Phe levels are also innocuous and/or may result in late effects.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- CMMS :
-
Columbia Mental Maturity Scale
- IQ :
-
intelligence quotient
- Phe :
-
phenylalanine
- PKU :
-
phenylketonuria
- WJSC-R :
-
Wechsler Intelligence Scale for Children — Revised
- WPPSI :
-
Wechsler Preschool and Primary Scale of Intelligence
References
Azen CG, Koch R, Friedman EG, Berlow St, Coldwell J, Krause W, Mat-alon R, McCabe E, et al (1991) Intellectual development in 12-year-old children treated for phenylketonuria. Am J Dis Child 145:35–39
Blaskovics ME (1986) Diagnosis in relationship to treatment of hyperphenylalaninaemia. J Inherited Metab Dis 9 [Suppl]:78–82
Burgard P, Armbruster M, Schmidt E, Rupp A (1995) Psychopathology of patients treated early for phenylketonuria: results of the German collaborative study of phenylketonuria. Acta Paediatr 83 [Suppl 407]: 108–110
Cattell RB (1963) Theory of fluid and crystallized intelligence: a critical experiment. Educ Psychol 54: 1–22
Collaborative study of children treated for Phenylketonuria (PKU) in the Federal Republic of Germany (1990) Eur J Pediatr [Suppl 1] 149
Diamond A (1994) Phenylalanine levels of 6–10 mg/dl may not be as benign as once thought. Acta Pädiatr [Suppl 407] 407: 89–91
Flynn JR (1987) Massive IQ gains in 14 nations: what IQ tests really measure. Psychol Bull 101:171–191
Følling A (1934) Über Ausscheidung von Phenylbrenztraubensäure in den Ham als Stoffwechselanomalie in Verbindung mit Imbezillität. Hoppe Seylers Z Physiol Chem 227: 169–176
Fuggle PW, Tokar S, Grant DB, Smith I (1992) Rising IQ scores in british children: recent evidence. J Child Psychol Psychiatry 33: 1241–1247
Krause W, Halminski M, McDonald L, Dembure P, Salvo R, Freides D, Elsas L (1985) Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria A model for the study of phenylalanine and brain function in man. J Clin Invest 75:40–48
Lou HC, Guttler F, Lykkelund C, Bruhn P, Niederwieser A (1985) Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for pheylketonuria in adolescents. Eur J Pediatr 144:17–20
Lutz P, Schmidt H, Batzler U (1990) Study design and description of patients. Eur J Pediatr 149 [Suppl 1]: 5–12
Mabry CC, Podoll E (1963) Above average intelligence in untreated phenylketonuria. J Pediatr 63:1038–1040
Matthews G, Dorn L (1989) IQ and choice reaction time: an information processing analysis. Intelligence 13: 299–317
Medical Research Council Working Party on Phenylketonuria (1993) Recomendations on the dietary management of phenylketonuria. Arch Dis Child 68: 426–427
Medical Research Council Working Party on Phenylketonuria (1993) Phenylketonuria due to phenylalanine hydroxylase deficiency: an unfolding story. BMJ 306: 115–119
Primrose DA (1983) Phenylketonuria with normal intelligence. J Ment Defic Res 27: 239–246
Ramus SJ, Forrest SM, Pitt DB, Saleeba JA, Cotton RGH (1993) Comparison of genotype and intellectual phenotype in untreated PKU patients. J Med Genet 30: 401–405
Rupp A, Burgard P (1995) The comparison of different idices of dietary control in phenylketonuria. Acta Paediatr 84: 521–527
Sattler JM (1988) Assessment of children, 3rd edn. Sattler Publisher, San Diego
Schaefer F, Burgard P, Batzler U, Rupp A, Schmidt H, Gilli G, Bickel H, Bremer HJ (1994) Growth and skeletal maturation in children with phenylketonuria. Acta Paediatr 83: 534–541
Schmidt E, Rupp A, Burgard P, Pietz J, Weglage J, Sonneville L de (1994) Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine-blood-level. J Clin Exp Neuropsychol 16: 681–688
Schulz B, Bremer HJ (1995) Nutrient intake and food consumption of adolescents and young adults with phenylketonuria. Acta Paediatr 84: 743–748
Smith I, Beasley MG, Ades AE (1990) Intelligence and quality of dietary treatment in phenylketonuria. Arch Dis Child 65:472–478
Stellungnahme der Arbeitsgemeinschaft für Pädiatrische Stoffwechselstörungen (APS) zur diätetische Behandlung der Phenylketonurie (1990) Monatsschr Kinderheilkd 138: 636
Waisbren SE, Schnell RR, Levy HL (1980) Diet termination in children with phenylketonuria: a review of psychological assessments used to determine outcome. J Inherited Metab Dis 3:149–53
Waisbren SE, Brown MJ, Sonneville LMJ de, Levy HL (1994) Review of neuropsychological functioning in treated phenylketonuria: an information processing approach. Acta Pädiatr [Suppl 407]: 98–103
Weglage J, Rupp A, Schmidt E (1994) Personality characteristics in patients with phenylketonuria treated early. Pediatr Res 35:611–613
Weinert FE, Schneider W Individual development from 3 to 12: findings from the Munich Longitudinal Study. Cambridge University Press, Cambridge (in press)
Welsh MC, Pennington BF, Oznoff S, Rouse B, McCabe ERB (1990) Neuropsychology of early-treated Phenylketonuria: specific executive function deficits. Child Dev 61: 697–1713
Williamson M, Dobson JC, Koch R (1977) Collaborative study of children treated for phenylketonuria: study design. Pediatrics 60: 815–821
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Burgard, P., Schmidt, E., Rupp, A. et al. Intellectual development of the patients of the German Collaborative Study of children treated for phenylketonuria. Eur J Pediatr 155 (Suppl 1), S33–S38 (1996). https://doi.org/10.1007/PL00014245
Issue Date:
DOI: https://doi.org/10.1007/PL00014245